Sigilon Therapeutics Inc. (SGTX) stock plunged in the current market trading. Let’s find out why?
Sigilon Therapeutics Inc. (NASDAQ: SGTX) stock declined by 29.27% in the current market trading session. Sigilon Therapeutics’ Shielded Living Therapeutics system aims to create functional treatments for chronic illnesses. Patients with chronic illnesses such as hemophilia, lysosomal diseases, and diabetes can benefit from Sigilon’s product candidates, which are non-viral engineered cell-based treatments that generate critical […]
Why Sigilon (SGTX) Stock Was Up In After-Hour Trades On Weekend?
Sigilon Therapeutics Inc. (NASDAQ: SGTX) shares settled at $14.95 in after-market trades, rising 7.55%. A price of $13.90 was reached Friday by Sigilon stock, closing the session -5.70% lower. There were 0.25 million shares of SGTX stock traded in the last session, which was more than 50-day average volume of 0.13 million shares. Within the […]
